These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 27160178)
1. Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells. Ruan H; Qiu S; Beard BC; Black ME Protein Eng Des Sel; 2016 Dec; 29(12):573-582. PubMed ID: 27160178 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine. Lemaire M; Momparler LF; Raynal NJ; Bernstein ML; Momparler RL Cancer Chemother Pharmacol; 2009 Feb; 63(3):411-6. PubMed ID: 18398609 [TBL] [Abstract][Full Text] [Related]
3. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase. Laliberté J; Marquez VE; Momparler RL Cancer Chemother Pharmacol; 1992; 30(1):7-11. PubMed ID: 1375134 [TBL] [Abstract][Full Text] [Related]
4. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene. Beauséjour CM; Eliopoulos N; Momparler L; Le NL; Momparler RL Cancer Gene Ther; 2001 Sep; 8(9):669-76. PubMed ID: 11593336 [TBL] [Abstract][Full Text] [Related]
5. Mutagenicity of the cytidine analog zebularine in Escherichia coli. Lee G; Wolff E; Miller JH DNA Repair (Amst); 2004 Feb; 3(2):155-61. PubMed ID: 14706349 [TBL] [Abstract][Full Text] [Related]
6. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells. Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252 [TBL] [Abstract][Full Text] [Related]
7. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells. Eliopoulos N; Cournoyer D; Momparler RL Cancer Chemother Pharmacol; 1998; 42(5):373-8. PubMed ID: 9771951 [TBL] [Abstract][Full Text] [Related]
8. Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside. Momparler RL; Laliberté J; Eliopoulos N; Beauséjour C; Cournoyer D Anticancer Drugs; 1996 May; 7(3):266-74. PubMed ID: 8791999 [TBL] [Abstract][Full Text] [Related]
9. Intracellular localization of human cytidine deaminase. Identification of a functional nuclear localization signal. Somasekaram A; Jarmuz A; How A; Scott J; Navaratnam N J Biol Chem; 1999 Oct; 274(40):28405-12. PubMed ID: 10497201 [TBL] [Abstract][Full Text] [Related]
10. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine. Neff T; Blau CA Exp Hematol; 1996 Sep; 24(11):1340-6. PubMed ID: 8862446 [TBL] [Abstract][Full Text] [Related]
11. Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice. Eliopoulos N; Bovenzi V; Le NL; Momparler LF; Greenbaum M; Létourneau S; Cournoyer D; Momparler RL Gene Ther; 1998 Nov; 5(11):1545-51. PubMed ID: 9930308 [TBL] [Abstract][Full Text] [Related]
12. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology. Marquez VE; Barchi JJ; Kelley JA; Rao KV; Agbaria R; Ben-Kasus T; Cheng JC; Yoo CB; Jones PA Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):305-18. PubMed ID: 16247946 [TBL] [Abstract][Full Text] [Related]
13. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Billam M; Sobolewski MD; Davidson NE Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041 [TBL] [Abstract][Full Text] [Related]
14. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts. Létourneau S; Palerme JS; Delisle JS; Beauséjour CM; Momparler RL; Cournoyer D Cancer Gene Ther; 2000 May; 7(5):757-65. PubMed ID: 10830723 [TBL] [Abstract][Full Text] [Related]
15. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. Marquez VE; Kelley JA; Agbaria R; Ben-Kasus T; Cheng JC; Yoo CB; Jones PA Ann N Y Acad Sci; 2005 Nov; 1058():246-54. PubMed ID: 16394141 [TBL] [Abstract][Full Text] [Related]
16. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate. Beauséjour CM; Le NL; Létourneau S; Cournoyer D; Momparler RL Hum Gene Ther; 1998 Nov; 9(17):2537-44. PubMed ID: 9853520 [TBL] [Abstract][Full Text] [Related]
17. Chemoprotection against cytosine nucleoside analogs using the human cytidine deaminase gene. Eliopoulos N; Beauséjour C; Momparler RL Prog Exp Tumor Res; 1999; 36():124-42. PubMed ID: 10386070 [No Abstract] [Full Text] [Related]
18. Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity. Gourdeau H; Bibeau L; Ouellet F; Custeau D; Bernier L; Bowlin T Cancer Chemother Pharmacol; 2001 Mar; 47(3):236-40. PubMed ID: 11320667 [TBL] [Abstract][Full Text] [Related]
19. Carbocyclic analogues of the potent cytidine deaminase inhibitor 1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine). Jeong LS; Buenger G; McCormack JJ; Cooney DA; Hao Z; Marquez VE J Med Chem; 1998 Jul; 41(14):2572-8. PubMed ID: 9651161 [TBL] [Abstract][Full Text] [Related]
20. Cytidine deaminase - the methodological relevance of AraC deamination for ex vivo experiments using cultured cell lines, fresh leukemic blasts, and normal bone marrow cells. Braess J; Pförtner J; Kern W; Hiddemann W; Schleyer E Ann Hematol; 1999 Nov; 78(11):514-20. PubMed ID: 10602895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]